Karen K Y Leung1,2, Samiran Ray3, Godfrey C F Chan4, Kam Lun Hon5. 1. Paediatric Intensive Care Unit, Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China. kkyleung@hku.hk. 2. Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China. kkyleung@hku.hk. 3. Paediatric Intensive Care Unit, Great Ormond Street Hospital NHS Foundation Trust, London, UK. 4. Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China. 5. Paediatric Intensive Care Unit, Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
Abstract
BACKGROUND: Advancements in cancer treatment have resulted in longer survival but often at the expense of new therapy-associated morbidities. The aim of this study is to evaluate functional outcomes of hemato-oncology patients at PICU discharge, and to identify associated risk factors. METHODS: A single-center retrospective observational study. All children (< 19 years) with a hemato-oncology diagnosis admitted to the Hong Kong Children's Hospital PICU over a 2-year period were included. Functional status upon admission and discharge were compared. Univariable and multi-variable analyses were employed to identify risk factors associated with new morbidities. RESULTS: Out of 288 PICU admissions, there were 277 live discharges (mortality 4%), of which 52 (18.8%) developed new morbidities. Emergency admission, severity of illness at admission, organ dysfunction and support were associated with new morbidities (OR 1.08-11.96; p < 0.05). Adjusting for confounding factors, higher Pediatric Logistic Organ Dysfunction 2 score at admission was significantly associated with development of new morbidities (OR 1.34; 95% CI 1.18-1.54; p < 0.001). CONCLUSION: Critically ill children with hemato-oncological diseases had a higher rate of developing new morbidities (18.8%) compared with the general PICU population (4-8%). This was associated with severity of illness at admission. Further work is warranted to understand the lasting effects of these new morbidities and mitigating interventions.
BACKGROUND: Advancements in cancer treatment have resulted in longer survival but often at the expense of new therapy-associated morbidities. The aim of this study is to evaluate functional outcomes of hemato-oncology patients at PICU discharge, and to identify associated risk factors. METHODS: A single-center retrospective observational study. All children (< 19 years) with a hemato-oncology diagnosis admitted to the Hong Kong Children's Hospital PICU over a 2-year period were included. Functional status upon admission and discharge were compared. Univariable and multi-variable analyses were employed to identify risk factors associated with new morbidities. RESULTS: Out of 288 PICU admissions, there were 277 live discharges (mortality 4%), of which 52 (18.8%) developed new morbidities. Emergency admission, severity of illness at admission, organ dysfunction and support were associated with new morbidities (OR 1.08-11.96; p < 0.05). Adjusting for confounding factors, higher Pediatric Logistic Organ Dysfunction 2 score at admission was significantly associated with development of new morbidities (OR 1.34; 95% CI 1.18-1.54; p < 0.001). CONCLUSION: Critically ill children with hemato-oncological diseases had a higher rate of developing new morbidities (18.8%) compared with the general PICU population (4-8%). This was associated with severity of illness at admission. Further work is warranted to understand the lasting effects of these new morbidities and mitigating interventions.
Authors: Michael C McCrory; Michael C Spaeder; Emily W Gower; Thomas A Nakagawa; Sean L Simpson; Mary A Coleman; Peter E Morris Journal: Pediatr Crit Care Med Date: 2017-10 Impact factor: 3.624
Authors: Rachel L Harrington; Dima M Qato; James W Antoon; Rachel N Caskey; Glen T Schumock; Todd A Lee Journal: Pediatr Blood Cancer Date: 2019-02-10 Impact factor: 3.167
Authors: Stephanie Senna; Chengsi Ong; Judith Ju-Ming Wong; John Carson Allen; Rehena Sultana; Jan Hau Lee Journal: Pediatr Crit Care Med Date: 2020-11 Impact factor: 3.624
Authors: Håkan Kalzén; Björn Larsson; Staffan Eksborg; Lars Lindberg; Karl Erik Edberg; Claes Frostell Journal: PLoS One Date: 2018-04-05 Impact factor: 3.240
Authors: Murray M Pollack; Richard Holubkov; Tomohiko Funai; Amy Clark; John T Berger; Kathleen Meert; Christopher J L Newth; Thomas Shanley; Frank Moler; Joseph Carcillo; Robert A Berg; Heidi Dalton; David L Wessel; Rick E Harrison; Allan Doctor; J Michael Dean; Tammara L Jenkins Journal: Pediatr Crit Care Med Date: 2014-11 Impact factor: 3.624